J. D. Mitchell

Three-dimensional reconstruction of ventricular septal defects: validation studies and in vivo feasibility.

J. Rivera, A. Weyman, R. Levine, 1994, Journal of the American College of Cardiology.

Operation for recurrent ventricular tachycardia. Predictors of short- and long-term efficacy.

J. Ruskin, G. Vlahakes, J. D. Mitchell, 1994, The Journal of thoracic and cardiovascular surgery.

Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.

J. Ruskin, G. Vlahakes, J. D. Mitchell, 1993, The Journal of thoracic and cardiovascular surgery.

Resection for bronchogenic carcinoma involving the carina: long-term results and effect of nodal status on outcome.

J. Wain, D. Mathisen, J. D. Mitchell, 2001, The Journal of thoracic and cardiovascular surgery.

Prevention of postoperative pericardial adhesions with a hyaluronic acid coating solution. Experimental safety and efficacy studies.

G. Vlahakes, J. D. Mitchell, W. Harringer, 1994, The Journal of thoracic and cardiovascular surgery.

Reduction in experimental pericardial adhesions using a hyaluronic acid bioabsorbable membrane.

G. Vlahakes, J. D. Mitchell, K. Neya, 1994, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Clinical experience with carinal resection.

J. Wain, D. Mathisen, J. D. Mitchell, 1999, The Journal of thoracic and cardiovascular surgery.

The Society of Thoracic Surgeons Clinical Practice Guidelines on Arterial Conduits for Coronary Artery Bypass Grafting.

J. D. Mitchell, J. Sabik, V. Thourani, 2016, The Annals of thoracic surgery.

The American Association for Thoracic Surgery/Society of Thoracic Surgeons position statement on developing clinical practice documents.

L. Svensson, G. Patterson, J. D. Mitchell, 2017, The Journal of thoracic and cardiovascular surgery.

Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non–small cell lung cancer

M. Kris, V. Rusch, I. Wistuba, 2022, The Journal of thoracic and cardiovascular surgery.